Spontaneous dimerization of ligand-responsive EGFR mutants

Stable Identifier
Reaction [binding]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

EGFR ligand-responsive mutants dimerize spontaneously, without ligand binding, although ligand binding ability is preserved. This was experimentally demonstrated for EFGR L858R mutant and is presumed to happen in other constitutively active EGFR kinase domain mutants and EGFR extracellular domain point mutants.

Literature References
PubMed ID Title Journal Year
17349580 Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity

Yun, CH, Boggon, TJ, Li, Y, Woo, MS, Greulich, H, Meyerson, M, Eck, MJ

Cancer Cell 2007
16187797 Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

Greulich, H, Chen, TH, Feng, WL, Jänne, PA, Alvarez, JV, Zappaterra, M, Bulmer, SE, Frank, DA, Hahn, WC, Sellers, WR, Meyerson, M

PLoS Med 2005
19560417 The juxtamembrane region of the EGF receptor functions as an activation domain

Red Brewer, M, Choi, SH, Alvarado, D, Moravcevic, K, Pozzi, A, Lemmon, MA, Carpenter, G

Mol Cell 2009
16777603 An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Zhang, X, Gureasko, J, Shen, K, Cole, PA, Kuriyan, J

Cell 2006
Functional status

Gain of function of Ligand-responsive EGFR mutants:HSP90:CDC37 [plasma membrane]

Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cite Us!